Today
July 25, 2026Dilution Risk
5Last 7DListing Risk
37Last 30DEarnings
9Last 7DInsider / Ownership
3Last 14DDividends
1Last 30DFDA / Clinical
7Last 30DSingularity Future Technology Ltd. is executing a 1-for-14 reverse stock split, effective July 27, 2026.
VYNE Therapeutics is executing a 1-for-50 reverse stock split, effective July 27, 2026.
Wheeler REIT is executing a 1-for-5 reverse stock split, effective July 28, 2026.
NAVER, Brookfield, and NVIDIA expand Korea's AI factory infrastructure to 200MW with $10B investment.
NVIDIA, Naver, and Brookfield expand Korea's AI factory infrastructure with a $1B NVIDIA investment.
PMI is halted for regulatory concern.
VYNE is halted for news pending.
SGLY is halted for news pending.
ZNB is halted for news pending.
STKH is halted for news pending.
Nasdaq will delist Sleep Number Corp's common stock, suspending trading on June 23, 2026, following the company's Chapter 11 bankruptcy filing.
Linkers Industries is offering up to 23.1M units, each containing a Class A Ordinary Share and two warrants. The Series B Warrants include a zero exercise price option, potentially issuing 346.3M Class A shares, leading to over 3,378.2% dilution.
Red Cat Holdings is conducting an underwritten public offering of 23.9 million common shares at $9.40 each, aiming to raise $213.9 million in net proceeds. This offering represents a 19.6% dilution to existing shareholders, with an additional 3.6 million shares available via an underwriters' option.
Eli Lilly & Co launched a tender offer to acquire Morphic Holding, Inc. for $57.00 per share in cash.
TransCode Therapeutics seeks shareholder approval for a reverse stock split to meet Nasdaq minimum bid price requirements and avoid delisting.
NVIDIA reported a 65.5% increase in revenue to $215.94 billion and a 64.7% rise in net income to $120.07 billion for fiscal year 2026, driven by strong AI and data center demand.
Rumble Inc. secured final regulatory approval for its business combination with Northern Data AG, paving the way for closing.
Bone Biologics Corp registered 6.46 million shares for resale by selling stockholders, primarily from warrants, which represents a substantial 357% of current outstanding shares. The company will not receive proceeds from the resale, but could get $6.2 million from warrant exercises.
Nikola Corp's common stock will be suspended from trading on Nasdaq effective February 26, 2025, following a Chapter 11 bankruptcy filing.
Icahn Enterprises proposed a tender offer to acquire up to 15 million additional shares of CVR Energy at $17.50 per share.